Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment

Revolution Medicines (RVMD) stock gained after the FDA granted early approval to Rasonque for pancreatic cancer, with trial data showing significant survival benefits.

The post Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment appeared first on Blockonomi.